Clinical research progress and implications of therapeutic vaccines for cervical cancer and precancerous lesions: a qualitative systematic review

Shan CAI; Ke MIAO; Xiao-Yu TAN; Si CHENG; Dan-Tong LI; Xue-Yang ZENG; Yu YANG; Ruo-Gu MENG; Zhi-Ke LIU; Yan LI; Ke-Li LI; Feng SUN; Si-Yan ZHAN.
Chinese Journal of Oncology ; (12): 743-760, 2022.
Artículo en Zh | WPRIM | ID: wpr-940935

Documentos relacionados

  1. [Clinical research progress and implications of therapeutic vaccines for cervical cancer and precancerous lesions: a qualitative systematic review].
  2. Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis.
  3. Advances in therapeutic vaccines for treating human papillomavirus-related cervical intraepithelial neoplasia.
  4. The Preventive Effect of Dietary Antioxidants on Cervical Cancer Development.
  5. Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions.
  6. Future Directions for Research on Anal Precancerous Lesion Treatment.
  7. Cervical cancer prevention and control in women living with human immunodeficiency virus.
  8. Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case-control study.
  9. Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis.
  10. Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years.